UP!

News

BioSpecifics Technologies Corp. -2.38% (healthcare)

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q4 2020 2021-03-15 Future report Set alerts
Q3 2020 2020-11-06 Future report Set alerts
Q2 2020 2020-08-10 0.11 0.02
Q1 2020 2020-05-11 0.61 0.61
Q4 2019 2020-03-16 1.00 1.00
Q3 2019 2019-11-08 0.85 0.85
Q2 2019 2019-08-09 0.87 0.87
Q1 2019 2019-05-10 0.60 0.60
Q4 2018 2019-04-02 0.84 0.84
Q3 2018 2018-11-09 0.69 0.69

Ratings

2016-06-13 Reiterated Rating Rodman & Renshaw Buy
2016-06-02 Reiterated Rating Rodman & Renshaw Buy
2016-03-08 Initiated Coverage Rodman & Renshaw Buy $60.00
2016-03-08 Reiterated Rating HC Wainwright Buy
2015-07-16 Initiated Coverage MLV & Co. Buy $76.00
2014-12-23 Reiterated Rating Aegis Positive
2014-11-11 Boost Price Target MKM Partners Buy $38.00 to $46.00
2014-08-12 Boost Price Target MKM Partners Buy $28.00 to $38.00
2014-01-09 Boost Price Target MKM Partners Buy $24.50 to $28.00
2013-12-09 Boost Price Target MKM Partners Buy $23.50 to $24.50
2013-11-13 Boost Price Target MKM Partners Buy $21.00 to $23.50
2013-10-22 Initiated Coverage JMP Securities Outperform $28.00
2012-04-05 Initiated MKM Partners Buy $26.50
2009-06-15 Initiated Hapoalim Outperform $40
2016-06-13 Reiterated Rating Rodman & Renshaw Buy
2016-06-02 Reiterated Rating Rodman & Renshaw Buy
2016-03-08 Initiated Coverage Rodman & Renshaw Buy $60.00
2016-03-08 Reiterated Rating HC Wainwright Buy
2015-07-16 Initiated Coverage MLV & Co. Buy $76.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
Estate of Edwin H. Wegman 15.52%  (1005179) BSTC /
Wegman Toby 15.13%  (980178) BSTC /
RA CAPITAL MANAGEMENT, LLC 9.67%  (626462) ACHN / ARDM / BSTC / DRNA / DSCI / SGMO /
Vogel Jeffrey Kenneth 5% Owner 7.85%  (508656) BSTC /
Wegman Thomas President 4.52%  (292549) BSTC /
Schamroth Michael 1.07%  (69000) BSTC /
Wegman Mark N 0.87%  (56494) BSTC /
Gitman Paul 0.80%  (51825) BSTC /
Morgan Henry 0.50%  (32193) BSTC /

Comments